C lustering of cell-surface insulin receptors is a wellestablished phenomenon (1) . In rat adipocytes (2) and placental syncytial trophoblasts (3), insulin receptors are found in small groups, whereas in other cell types, receptors rapidly cluster after the addition of insulin to cells (1) . Although the data are incomplete, receptor clustering has been implicated as an important step in insulin action (4) . Kahn et al. (4) have shown that the insulinomimetic effects of anti-receptor antibodies are dependent on the use of bivalent antibodies. Monovalent fragments of these antibodies had no insulin-like effects. Importantly, the addition of a secondary antibody, which cross-links the monovalent fragments, restored the insulinlike effects (4) . The mechanism by which clustering affects insulin action is unknown.
The insulin receptor is a tyrosine-specific protein kinase. After hormone binding, the receptor p-subunit rapidly undergoes autophosphorylation, resulting in activation of the intrinsic kinase activity of the receptor. There is now a large body of evidence supporting the hypothesis that receptor autophosphorylation is an early step in the transmission of the insulin-binding signal (5) . It has been speculated that binding of insulin to a single receptor in a cluster could lead to phosphorylation of the remaining receptors in the group (1). This would result in an amplification of the initial insulinbinding signal.
Although dilution analysis indicates that receptor autophosphorylation is an intramolecular event (6,7), this does not preclude the possibility that under certain conditions, intermolecular phosphorylation can occur. In fact, with monovalent and bivalent fragments of insulinomimetic anti-receptor antibodies analogous to those described above, it was found that bivalency was required for stimulation of receptor phosphorylation (8) . This again indicates, at least for anti-receptor antibodies, that receptor clustering is required for insulin-like effects.
In this study, we used highly purified insulin receptors to examine whether receptors that have been activated by autophosphorylation in the presence of insulin can phos-l from Du Pont-NEN (Boston, MA), and all other reagents were reagent grade or better.
Rat liver plasma membranes were isolated as described by Lesko et al. (9) , and human placental membranes were prepared as described by Fujita-Yamaguchi et al. (10) . Insulin receptors were purified by affinity chromatography on wheat-germ agglutinin-agarose and insulin-Affi-gel 10 (BioRad, Richmond, CA) (10) and concentrated by DEAE-cellulose chromatography (11) . In some experiments, human insulin receptors were purified by immunoaffinity chromatography with the monoclonal anti-receptor antibody a-IR1 (12) essentially as described by Roth et al. (13) . Relative receptor concentration was determined by specific binding of 125 l-labeled insulin (1.5 x 10~1 0 M) to purified receptor preparations as described previously (14) .
To produce inactive and activated receptors, rat liver receptors were incubated in the absence or presence of 10 nM insulin with 25 \dA ATP, 2 mM MnCI 2 , 10 mM MgCI 2 , 50 mM Tris-HCI (pH 7.4), 0.1 M NaCI, 0.1% Triton X-100, 0.5 mg/ml bovine serum albumin (BSA), and 1 mM sodium vanadate. Incubation was performed at 24°C for 20 min and was stopped by addition of 4 fxl of 0.3 M EDTA. Insulin was removed by incubation for 1 h at 0°C with anti-insulin antibody bound to Pansorbin (Calbiochem, San Diego, CA). These conditions were found to be optimal as determined with 10 nM unlabeled insulin and tracer 125 l-insulin. With A14-125 l-insulin, 100% of the radioactive insulin was immunoprecipitated in the presence of 10 nM unlabeled insulin. The counts remaining in the supernatant did not coelute with insulin on Sephadex G-50 chromatography. Pansorbin was removed by centrifugation and the clarified supernatant used as a source of inactive and activated receptors. Although vanadate may increase receptor phosphorylation (15) , it was included in the assay mixture to inhibit phosphatase activity in the anti-insulin antibody preparation. However, the concentration of vanadate was constant in all phosphorylation mixtures and, therefore, could not account for any observed changes in receptor phosphorylation. Inactive and activated rat receptors were mixed with nonphosphorylated human insulin receptors and incubated for 20 min at 24°C with 25 IJLM [ 32 P]ATP (2.5 jiCi/nmol), as described above. Reactions were stopped by addition of 10 mM ATP, 1 mM vanadate, and 10 mM EDTA, and human receptors were specifically immunoprecipitated with MA-20 and Pansorbin, then analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (16) . Initial experiments showed that MA-20 failed to immunoprecipitate rat liver insulin receptors (data not shown).
In experiments with varying concentrations of receptors, human insulin receptors, at concentrations equivalent to the concentration of rat receptors used, were activated as described above. Increasing concentrations of nonphosphorylated receptors were mixed with activated receptors, and phosphorylation was initiated by the addition of [ 32 P]ATP and divalent ions. After incubation at 24°C for 20 min, reactions were stopped by addition of 3.8% SDS and 5% mercaptoethanol and analyzed by SDS-PAGE. As a control, activated receptors and increasing concentrations of nonphosphorylated receptors were separately incubated with [ 32 P]ATP and divalent ions and mixed after termination of the phosphorylation reaction. Because the entire assay mixture was analyzed by SDS-PAGE, a phosphorylated band migrating with the BSA was present in the assay mixture. The control experiments contained greater amounts of BSA than the mixtures of activated and nonphosphorylated receptors. This resulted in increased labeling of this band in the control lanes.
RESULTS
In our initial studies, rat liver insulin receptors were used as a source of activated kinase and nonphosphorylated human insulin receptors as substrate. Because MA-20 specifically precipitates the human receptor, it allowed us to examine phosphorylation of the substrate separately from autophosphorylation of the rat receptors used as activated enzyme. Control experiments were performed to determine whether the purified rat liver insulin receptors were capable of insulinstimulated tyrosine kinase activity. Autophosphorylation of purified rat liver insulin receptors was stimulated 3-to 5-fold by 10 nM insulin. To verify that receptors, which had been previously incubated with insulin, exhibit increased kinase activity toward substrates, we examined Glu phosphorylation (14) . The tyrosine kinase activity of insulinfree activated receptors was increased 2.2-fold over the activity of inactive receptors (data not shown). These data demonstrate that activated receptors, after removal of insulin, have enhanced intermolecular kinase activity for a well-described substrate.
Purified human insulin receptors also underwent insulinstimulated autophosphorylation (Fig. 1) . In addition, when a solution of 10 nM insulin, which had been incubated with anti-insulin antibody-Pansorbin complex, was added to the autophosphorylation reactions, there was no increase in receptor phosphorylation compared with controls ( Fig. 1, lanes  1 and 2) . This demonstrates the efficacy of the conditions used for removal of insulin from activated receptors.
The addition of insulin-free activated rat receptors capable of enhancing Glu 80 Tyr 20 phosphorylation had no effect on the phosphorylation of human receptors when compared with the addition of inactive rat receptors (Fig. 2) . As a control, we examined the ability of insulin (10 nM) to stimulate autophosphorylation of human insulin receptors in the presence of the rat receptors. The presence of activated rat receptors did not hinder or enhance phosphorylation of human receptors. These data indicate that, under these conditions, the human insulin receptor was not a substrate for rat insulin receptors.
The negative results obtained above could have been due to a concentration of human receptors that was too low to permit intermolecular phosphorylation. Because of the limited availability of monoclonal antibody, it was not possible to examine higher receptor concentrations with mixtures of rat and human receptors. Therefore, human insulin receptors at a concentration equal to the rat receptors used above
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pu^^^ "^^^^G^w ^t^H^Br receptors before initiation of phosphorylation resulted in increased incorporation of 32 P into the p-subunit of the insulin receptor ( Fig. 3; lane 10 is greater than lane 9) . This indicates that, at high receptor concentrations, intermolecular phosphorylation can occur. In the four experiments where a 40-fold increase in receptor concentration was employed, intermolecular phosphorylation, assessed by densitometric scanning, was always observed (mean ± SE 1.47 ± 0.07-fold increase). At a 20-fold increase in receptor concentration, intermolecular phosphorylation was observed in two of five experiments. Based on Coomassie blue staining of the gel, a 40-fold increase in receptor used as substrate was equivalent to a receptor concentration of 60 (xg/ml. Intermolecular receptor phosphorylation was not detected at lower receptor concentrations.
DISCUSSION
Early studies examining the mechanism of receptor phosphorylation suggested that receptor autophosphorylation was only an intramolecular event (6,7). However, this does not rule out the occurrence of intermolecular phosphorylation at high receptor concentrations. Petruzelli et al. (7) employed a maximum receptor concentration less than the concentra- were employed as a source of activated receptors. Concentrations of nonphosphorylated human receptors up to 40-fold greater than those described above were mixed with activated receptors, phosphorylated in the presence of [ 32 P]ATP, and analyzed directly by SDS-PAGE. Because this methodology does not separate activated receptors from the receptors used as substrate, the extent of intramolecular phosphorylation of both receptor populations had to be considered. The total amount of intramolecular phosphorylation was determined by separately incubating increasing concentrations of nonphosphorylated receptors and a constant concentration of insulin-free activated receptors with [ 1 and 2) or presence (lanes 3 and 4) of insulin, human receptors were specifically immunoprecipitated and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography as described in Fig. 1 tion of receptors employed in our experiments mixing rat and human receptors. Although Shia et al. (6) examined autophosphorylation over a 50-fold concentration range, the receptor concentration employed can not be determined, because a partially purified receptor preparation was used. Ballotti et al. (17) have suggested that receptor phosphorylation may occur by an intermolecular mechanism. They examined phosphorylation in cells coexpressing a tyrosine kinase-deficient insulin receptor (K1018A) and a chimera consisting of the extracellular domain of the epidermal growth factor (EGF) receptor and the cytoplasmic domain of the insulin receptor. Stimulation of these cells with EGF resulted in tyrosine phosphorylation of the defective insulin receptor (17) . Also, EGF stimulated the phosphorylation of purified K1018A by the chimeric receptor in vitro (17) .
Based on the rapid formation of insulin-receptor clusters after insulin binding, it has been suggested that phosphorylation of unoccupied receptors by receptors that have bound insulin would be an efficient mechanism for amplification of the insulin-binding signal (1) . Studies with antireceptor antibodies have shown that bivalency is required for insulinlike effects, supporting a role for receptor clustering in insulin action (4) . In contrast, chemical agents that disrupt the naturally occuring receptor clusters in rat adipocytes had no effect on insulin action (18) . However, note that receptor clustering was not completely disrupted in these studies (18) . Although our in vitro experiments required receptor concentrations of >30 u-g/ml, intermolecular phosphorylation in situ may be more efficient as suggested by studies with receptor chimeras and kinase-deficient receptors (17) . Our data is the first to show that the insulin receptor per se is capable of intermolecular phosphorylation. This could be the first amplification step in transmitting the signal generated by insulin binding.
